At-home tests, once considered an anomaly, became de rigueur during the COVID-19 pandemic. Now, as COVID-19 testing rates decline from their pandemic peak, diagnostic companies businesses are seeing an opportunity in direct-to-consumer testing.
“Never before has the general population been more aware of in vitro diagnostics and the relevance of our industry than in the last two years with COVID-19,” said Jenna Urquhart, head of new franchise business development for Siemens Healthineers, “Thanks to the prevalence of rapid antigen tests, people have learned that it is possible to collect a sample, run a test, and receive results in minutes, all in the comfort of their own homes.”
Four of the largest diagnostics firms surveyed by MedTech Dive said they plan to continue offering COVID-19 testing and will add other types of at-home tests. Some companies said they see an opportunity in detecting other infectious diseases, while others expect increasing demand from patients managing chronic health conditions.
To read more, CLICK HERE.